Table: Taiko Pharmaceutical - 9-MTH group results

Taiko Pharmaceutical

10/02/2020 06:00

Feb 10 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               10.09               7.19             13.60    
                   (+40.4 pct)         (+7.1 pct)       (+30.5 pct) 
  Operating            3.20               1.90              3.00    
                   (+68.8 pct)         (+0.8 pct)       (+47.8 pct) 
  Recurring            3.07               1.81              2.75    
                   (+69.8 pct)         (+6.1 pct)       (+45.9 pct) 
  Net                  2.13               1.29              1.85    
                   (+65.3 pct)         (+11.5 pct)      (+30.7 pct) 
  EPS              149.92 yen           90.07 yen       130.40 yen  
  EPS Diluted      149.75 yen           89.94 yen                   
  Ann Div                               35.00 yen        40.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               25.00 yen        30.00 yen  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T